
Results from a study presented at the 2021 American Urologic Association Annual Meeting, found promising diagnostic performance of the electric nose (eNose) in detecting volatile organic compounds (VOCs) in urinary samples of patients with prostate cancer.
source: Janelle Hart - Urology Times